HRT vs GLP-1 for Menopause Weight Gain: Which Should You Start First?

The best first step depends on your main problem, and for many women the honest answer is to treat both in the order that matches their symptoms and health risks. Hormone replacement therapy (HRT) replaces the estrogen, and sometimes progesterone, that your ovaries stop making. A GLP-1 receptor agonist (a drug like semaglutide or tirzepatide that mimics a gut hormone) lowers appetite and blood sugar.

They do different jobs. HRT is the most effective treatment for hot flashes and night sweats, and it treats vaginal dryness and helps prevent bone loss. It is not approved or recommended for weight loss. GLP-1 drugs are approved for weight management and type 2 diabetes. They are not approved for menopause symptoms.

If you are bothered most by hot flashes, broken sleep, or painful sex, HRT is often the natural place to start. If your main concern is obesity, prediabetes, or a high heart risk, a GLP-1 may deserve priority. If you have both, your clinician may start one, check how you do, and add the other.

Our guide on [whether it is safe to take HRT and a GLP-1 together](/blog/hrt-and-glp1-together-is-it-safe-to-take-both) covers combined use. This article helps you think through sequence and expectations.

HRT does not cause weight gain, and it is not a weight loss drug, but it may help prevent some belly fat build-up. The weight many women gain in midlife is mostly driven by aging, muscle loss, less activity, poor sleep, and the shift in where fat is stored.

The SWAN study (Greendale et al., JCI Insight 2019) tracked body composition across the transition. It found fat mass rising and lean mass falling in the years around the final period, independent of aging alone. Estrogen loss is one reason fat shifts toward the belly.

Studies of HRT suggest it can reduce the increase in abdominal fat. A review by Davis and colleagues (Climacteric 2012) found that women on HRT had less central fat gain than women not using it. The effect on the scale is small, usually a few pounds at most, and results vary.

Sleep is a hidden pathway. HRT often improves sleep by reducing night sweats, and better sleep helps appetite control. Our article on [whether HRT causes weight gain](/blog/does-hrt-cause-weight-gain-what-the-evidence-shows) reviews the research in detail.

If you expect HRT alone to take off 20 or 30 pounds, you may be disappointed. If you expect it to make you feel better so that diet and exercise are easier to keep up, that is a realistic benefit.

A GLP-1 takes off far more weight than HRT. In the STEP 1 trial (NEJM 2021), adults using semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks, versus 2.4% with placebo. In SURMOUNT-1 (NEJM 2022), tirzepatide 15 mg led to an average loss of 20.9% over 72 weeks.

To put numbers in context, a 200 pound woman losing 15% would lose about 30 pounds. That is a scale of change that hormone therapy has never been shown to produce.

GLP-1 drugs also work after menopause. Observational data suggest postmenopausal women respond well, and there is research on how visceral fat responds. Our article on [whether GLP-1s work as well after menopause](/blog/do-glp1s-work-as-well-after-menopause-visceral-fat-evidence) goes through it.

But GLP-1 drugs do not treat hot flashes directly. Some women feel better as they lose weight, and some studies suggest fewer hot flashes with weight loss, but this is not a substitute for symptom treatment. The drugs also carry their own side effects, like nausea and constipation, and cost can be a barrier. They require ongoing use to keep the weight off, as shown in the STEP 1 extension.

Starting HRT first makes sense when menopause symptoms are your biggest burden, you are within 10 years of menopause, and you are under 60. This is the window in which the benefits generally outweigh the risks for healthy women, according to The Menopause Society's 2022 position statement.

Typical reasons to lead with HRT include frequent hot flashes, night sweats that wreck your sleep, mood swings tied to the transition, vaginal dryness, and early menopause. Women who had surgical menopause or premature ovarian insufficiency before age 45 are usually advised to take HRT until the average age of natural menopause, unless there is a reason not to. See our article on [surgical menopause and HRT timing](/blog/surgical-menopause-after-oophorectomy-why-hrt-timing-matters).

Starting HRT first also lets you see how much of your weight problem is tied to sleep and symptoms. Some women find their cravings, energy, and exercise routine improve once their nights are quiet.

There is also bone protection. Estrogen slows bone loss, which matters because rapid weight loss can also reduce bone density. Having bone protection in place before a GLP-1 may be an advantage. For details, read [the HRT window of opportunity](/blog/the-hrt-window-of-opportunity-why-timing-matters).

Who should not start HRT? People with a history of certain breast cancers, unexplained vaginal bleeding, active blood clots, or liver disease usually cannot. Your clinician will check.

Starting a GLP-1 first makes sense when obesity-related health risks are your main concern. That includes a BMI of 30 or higher, or 27 or higher with a weight-related condition like high blood pressure, prediabetes, sleep apnea, or fatty liver. The SELECT trial (NEJM 2023) showed semaglutide cut major cardiovascular events by 20% in adults with heart disease and overweight.

It may also be the better first step if your menopause symptoms are mild, if you cannot take HRT, or if you are past the 10-year window where HRT risks may be higher. Women over 60 should talk through risks carefully. Our article on [starting HRT after 60](/blog/starting-hrt-after-60-is-it-too-late) covers this.

A GLP-1 first can also be reasonable if you need a faster change in metabolic health, for example prediabetes that is moving toward diabetes. In that case, the proven benefits of weight loss may outweigh a delay in hormone treatment.

If you start a GLP-1 first, protect muscle and bone from day one. Aim for strength training twice a week and enough protein. Rapid weight loss in menopause raises the risk of muscle and bone loss, as covered in our guide to [the bone density double risk](/blog/glp1-bone-density-in-menopause-the-double-risk). Adding HRT later is still possible if symptoms persist.

For most women, yes, and many clinicians do prescribe both. HRT has a long safety record when started in the right window, and GLP-1 drugs have large trials supporting their safety for weight management. The WHI 30-year follow-up (Manson, JAMA 2024) found HRT was not linked to higher all-cause mortality over time.

The main practical question is absorption. GLP-1 drugs slow stomach emptying, which can change how quickly oral medicines are absorbed. The tirzepatide label advises that oral birth control may be less effective, and women should switch to non-oral contraception or add a barrier method for four weeks after starting and after each dose increase. Oral estrogen has not been shown to fail in the same way, but a transdermal option (a patch or gel absorbed through the skin) avoids the gut entirely. Our guide to [GLP-1 and HRT absorption](/blog/glp1-and-hrt-absorption-does-your-hormone-therapy-still-work) explains the details.

Micronized progesterone, usually taken as a capsule at bedtime, can cause drowsiness, which may stack with fatigue from a GLP-1. Start low and talk with your clinician.

Some observational studies suggest women using both lose more weight than those using a GLP-1 alone, but these studies cannot prove cause. Hot flash control may help sleep and adherence. Stay in touch with your care team after each change, since two drugs mean more things to monitor.

Bring your top two goals and your top three symptoms to the visit. Ask which problem is most urgent and which treatment addresses it. Be ready to share your medical history: breast cancer, blood clots, migraine with aura, liver disease, high blood pressure, and family history all shape the choice. Our article on [talking to your doctor about GLP-1 and menopause](/blog/talking-to-your-doctor-about-glp1-and-menopause-what-to-ask) has a question list.

Useful tests include blood pressure, A1C or fasting glucose, lipid panel, a DXA bone density scan if you are at risk, and a review of your medicines. If you are still having periods, ask about contraception, since GLP-1 drugs can improve fertility.

Agree on a plan with checkpoints. For example: start HRT, review symptoms and sleep in 12 weeks, then add a GLP-1 if weight and metabolic markers have not improved. Or start a GLP-1, build muscle-protecting habits, and review hot flashes at 12 weeks.

There is no prize for doing everything at once. Introducing one medicine at a time makes side effects easier to sort out. Whatever you choose, keep the basics steady: protein, strength work, sleep, and daily movement help whichever path you take.

Tracking turns a vague sense of feeling worse into data your doctor can use. For two weeks before your visit, write down hot flashes and night sweats per day, hours of sleep, mood, appetite, and energy. Log your weight once a week and your waist measurement once a month.

If you have a home blood pressure cuff, record readings. If you have a wearable, note resting heart rate and sleep trends. Our guide on [what to log in a GLP-1 and menopause symptom tracker](/blog/glp1-menopause-symptom-tracker-what-to-log-and-why) lists the most useful items.

After you start a treatment, keep tracking. Many HRT benefits show up in two to four weeks for hot flashes and sleep, and up to three months for full effect. GLP-1 weight loss begins within weeks and builds over months with dose increases.

Lea can combine these into one view, so you can see whether sleep improved before weight changed, or whether a dose increase lines up with a rough week. That makes it easier to have a calm, specific conversation with your clinician.